LiveScience reports that a promising new cancer vaccine cured 97 percent of tumors in mice. The successful trial of the vaccine on mice paves the way for trials on human subjects. Researchers from Stanford University will test the therapy on 35 people with lymphoma by the end of the year, according to the report. According to SFGate, the trial is part of a research into immunotherapy, a type of treatment that fights cancer by using the body’s immune system to attack tumors.
The treatment is not a true vaccine that creates lasting immunity but it features a vaccine-like injection carrying two immune stimulators that activate the immune system’s T cells to destroy tumors in the body. Immunotherapy is more promising because chemotherapy does not cure cancer and comes with many side effects.
0 comments :
Post a Comment